(Q44353221)

2 December 2017

title

A system for the production and delivery of monodisperse salbutamol aerosols to the lungs (English)

1 reference

2 December 2017

0 references

Martyn F Biddiscombe

1

1 reference

2 December 2017

Omar S Usmani

series ordinal

2

1 reference

2 December 2017

Peter J Barnes

series ordinal

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

International Journal of Pharmaceutics

2 December 2017

published in

1 reference

2 December 2017

volume

254

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

243-253

1 reference

Tracheobronchial clearance in patients with pulmonary sarcoidosis

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

The effect of area dosage, solution concentration and drop size of sprayed solutions and emulsions of DDT against mosquito larvae.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

Spinning-top homogeneous aerosol generator with shockproof mounting

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

Time-of-flight aerodynamic particle size analyzers: their use and limitations for the evaluation of medical aerosols.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

An evaluation of the physical properties of monodisperse and heterodisperse aerosols used in the assessment of bronchial function

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

Deposition of pressurised aerosols in the human respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

Dose-response effects of two sizes of monodisperse isoproterenol in mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

Effect of lung function and mode of inhalation on penetration of aerosol into the human lung

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

Mucociliary function in health, chronic obstructive airway disease, and asbestosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

The optimal particle size for β-adrenergic aerosols in mild asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900032-2

7 January 2021

10.1016/S0378-5173(03)00032-2

Identifiers

DOI

1 reference

2 December 2017

1 reference